New targets for surfactant replacement therapy: experimental and clinical aspects.
作者信息
Robertson B
机构信息
Department of Women's and Child Health, Karolinska Hospital, Stockholm, Sweden.
出版信息
Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F1-3. doi: 10.1136/fn.75.1.f1.
Abstract
摘要
相似文献
1
New targets for surfactant replacement therapy: experimental and clinical aspects.表面活性剂替代疗法的新靶点：实验与临床方面
Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F1-3. doi: 10.1136/fn.75.1.f1.
2
Surfactant. Evolving issues.表面活性剂。不断演变的问题。
Clin Perinatol. 1998 Mar;25(1):17-32.
3
Advances with surfactant.表面活性剂的进展。
Emerg Med Clin North Am. 2008 Nov;26(4):921-8, viii. doi: 10.1016/j.emc.2008.08.001.
4
Surfactant replacement therapy. An update on applications.表面活性剂替代疗法。应用进展
Pediatr Clin North Am. 1998 Jun;45(3):549-72. doi: 10.1016/s0031-3955(05)70027-4.
5
[Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].[表面活性剂治疗急性肺衰竭。除新生儿呼吸窘迫综合征之外的其他适应证]
Tidsskr Nor Laegeforen. 1997 Apr 20;117(10):1456-8.
6
Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.新生儿表面活性剂替代疗法：超越呼吸窘迫综合征
Respir Care. 2009 Sep;54(9):1203-8.
7
Use of surfactant beyond respiratory distress syndrome, what is the evidence?除了呼吸窘迫综合征之外，还在哪些情况下使用表面活性剂？有哪些证据？
J Perinatol. 2024 Apr;44(4):478-487. doi: 10.1038/s41372-024-01921-7. Epub 2024 Mar 8.
8
Pulmonary surfactant for neonatal respiratory disorders.用于新生儿呼吸系统疾病的肺表面活性物质。
Curr Opin Pediatr. 2003 Apr;15(2):149-54. doi: 10.1097/00008480-200304000-00002.
9
[Use of surfactants in neonatology].[表面活性剂在新生儿学中的应用]
Med Pregl. 2005 May-Jun;58(5-6):229-30.
10
Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.用于早产和足月新生儿呼吸窘迫的表面活性剂替代疗法。
Pediatrics. 2008 Feb;121(2):419-32. doi: 10.1542/peds.2007-3283.
本文引用的文献
1
Surfactant replacement therapy for meconium aspiration syndrome.胎粪吸入综合征的表面活性剂替代疗法。
Pediatrics. 1996 Jan;97(1):48-52.
2
Surfactant therapy in full-term neonates with severe respiratory failure.足月新生儿严重呼吸衰竭的表面活性剂治疗
Pediatrics. 1993 Jul;92(1):135-9.
3
Surfactant inhibition in experimental meconium aspiration.实验性胎粪吸入中的表面活性剂抑制作用
Acta Paediatr. 1993 Feb;82(2):182-9. doi: 10.1111/j.1651-2227.1993.tb12635.x.
4
Biochemical immaturity of lungs in congenital diaphragmatic hernia.
J Pediatr Surg. 1993 Mar;28(3):471-5; discussion 476-7. doi: 10.1016/0022-3468(93)90250-o.
5
Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration.
Biol Neonate. 1993;63(2):96-104. doi: 10.1159/000243917.
6
Pulmonary surfactant therapy.肺表面活性物质疗法
N Engl J Med. 1993 Mar 25;328(12):861-8. doi: 10.1056/NEJM199303253281208.
7
Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation.对于需要体外膜肺氧合的足月儿呼吸衰竭，外源性表面活性剂治疗后肺部结局改善。
J Pediatr. 1993 Feb;122(2):261-8. doi: 10.1016/s0022-3476(06)80131-9.
8
Pathophysiology of congenital diaphragmatic hernia. V. Effect of exogenous surfactant therapy on gas exchange and lung mechanics in the lamb congenital diaphragmatic hernia model.先天性膈疝的病理生理学。V. 外源性表面活性剂治疗对羔羊先天性膈疝模型气体交换和肺力学的影响。
J Pediatr. 1994 Feb;124(2):289-93. doi: 10.1016/s0022-3476(94)70322-1.
9
Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.外源性表面活性物质（Exosurf）介导的对人肺泡巨噬细胞刺激后细胞因子反应的抑制作用的特性研究
Am J Respir Cell Mol Biol. 1994 Apr;10(4):399-404. doi: 10.1165/ajrcmb.10.4.8136155.
10
Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome.
Chest. 1994 Jan;105(1):195-202. doi: 10.1378/chest.105.1.195.
Zotero 插件